If you didn't find what you were looking for, try a new search!
Lifebit Biotech Ltd – the leading precision medicine software company democratising access to biomedical data of governments, biobanks and healthcare providers for research teams worldwide – has raised a $60 million Series B funding round, led by global investment firm Tiger Global Management. Existing investors Eurazeo, Pentech Ventures, and Beacon Capital also participated. Despite [...]
Genomenon announced that it has completed a $5.3M financing round in the company. The financing will enable the company to expand its commercial operations, which serve genetic testing labs, hospitals, pharmaceutical and biopharma companies. Genomenon leverages AI (Artificial Intelligence) to organize the world’s genomic knowledge and put it at the fingertips of doctors and [...]
ABOUT US Editorial Advisory Board As Precision Medicine has changed over the past several years, we have been diligent in ensuring that the composition of our Editorial Advisory Board reflects those changes. Our EAB represents how precision medicine has come to expand beyond cancer and sequencing to embrace other [...]
Acceleration of Adoption of High Complexity Precision Diagnostics in Oncology by Global Public Healthcare Systems: A Case Study of Europe and Beyond Iain D. Miller, Ph.D. Précis Clinical impact in the “post-genome” years following the 2003 publication of the first human genome sequence map was much slower than many anticipated. For a host of technical [...]
Fighting for Their Lives – The Battle of the BPAN Warriors By Mark Kiel and Lauren Chunn Sarah Chisholm didn’t want to start a rare disease foundation – she had to. Her life changed forever when her daughter Eva was diagnosed with beta-propeller protein-associated neurodegeneration, or BPAN, a rare genetic condition caused by mutations in [...]
ARCHIVE ISSUES - DECEMBER 2019 A Case Study of Europe and Beyond Fighting for Their Lives – The Battle of the BPAN Warriors BPAN Warriors: A Rare Disease Community’s Search for Connection, Collaboration and a Cure Special Report: The Evolution of Biomarker Use in Clinical Trials for [...]
The Center for Applied Genomics at The Children’s Hospital of Philadelphia – Pediatric Perspectives on Genomic Medicine by John J Connolly, Joseph T Glessner, Dong Li, Patrick MA Sleiman and Hakon Hakonarson Pediatric Perspectives on Genomic Medicine The Center for Applied Genomics (CAG) is one of the Centers of Emphasis at The Children’s Hospital of [...]
Quick takes: Q&A with Marielena Mata on International Activities in Precision Medicine, Biomarkers, and Companion Diagnostics An interview with Marielena Mata, Director and Diagnostic Lead at Pfizer on International Activities in Precision Medicine, Biomarkers, and Companion Diagnostics Pfizer is focused on precision medicine as an approach to discovering and developing medicines and vaccines that deliver [...]
Majors, Organizational Legitimacy and Rents from Blockbuster Innovation in the Biopharma Industry by Ram Mudambi, Solon Moreira, Michael Carleton and Thomas Fare I. Intuitive summary and rationale We analyze the phenomenon of “Majors” – those firms that hold central positions in an industry and are consistently able to achieve outsized market success. Majors dominate a [...]
ARCHIVE ISSUES - MARCH 2020 Personalized Medicine in the Aftermath of COVID-19 Quick takes: Q&A with Jeff Evelhoch on Imaging Biomarkers for Alzheimer’s Disease Something to Smile About: The Journey Toward a Cure with Rare Disease Foundation NFED The Center for Applied Genomics at The Children’s [...]
